Literature DB >> 19770399

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease.

Kevin Steel1, Ryan Broderick, Vijay Gandla, Eric Larose, Frederick Resnic, Michael Jerosch-Herold, Kenneth A Brown, Raymond Y Kwong.   

Abstract

BACKGROUND: Recent studies have demonstrated the significant prognostic value of stress cardiac magnetic resonance (CMR) myocardial perfusion imaging. Apart from characterizing reversible perfusion defect (RevPD) from flow-limiting coronary stenosis, CMR late gadolinium enhancement (LGE) imaging is currently the most sensitive method for detecting subendocardial infarction (MI). We therefore tested the hypothesis that characterization of these 2 processes from coronary artery disease by CMR can provide complementary prognostic values. METHODS AND
RESULTS: We performed CMR myocardial perfusion imaging followed by LGE imaging on 254 patients referred with symptoms of myocardial ischemia. At a median follow-up of 17 months, 49 cardiac events occurred, including 12 cardiac deaths, 16 acute MIs, and 21 cardiac hospitalizations. RevPD and LGE both maintained a >3-fold association with cardiac death or acute MI (death/MI) when adjusted for each other and for the effects of patient age and gender (adjusted hazard ratio, 3.31; P=0.02; and hazard ratio, 3.43; P=0.01, respectively). In patients without a history of MI who had negative RevPD, LGE presence was associated with a >11-fold hazards increase in death/MI. Patients with neither RevPD nor LGE had a 98.1% negative annual event rate for death/MI. For association with major adverse cardiac events, RevPD was the strongest multivariable variable in the best overall model (hazard ratio, 10.92; P<0.0001).
CONCLUSIONS: CMR imaging provides robust risk stratification for patients who present with symptoms of ischemia. Characterization of RevPD and LGE by CMR provides strong and complementary prognostic implication for cardiac death or acute MI.

Entities:  

Mesh:

Year:  2009        PMID: 19770399      PMCID: PMC2766555          DOI: 10.1161/CIRCULATIONAHA.108.812503

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Waren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

Review 4.  Assessment of ventricular function and mass by cardiac magnetic resonance imaging.

Authors:  Khaled Alfakih; Scott Reid; Tim Jones; Mohan Sivananthan
Journal:  Eur Radiol       Date:  2004-07-17       Impact factor: 5.315

5.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

6.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

7.  Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.

Authors:  Cosima Jahnke; Eike Nagel; Rolf Gebker; Thomas Kokocinski; Sebastian Kelle; Robert Manka; Eckart Fleck; Ingo Paetsch
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

8.  Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort.

Authors:  Carol J Salton; Michael L Chuang; Christopher J O'Donnell; Michelle J Kupka; Martin G Larson; Kraig V Kissinger; Robert R Edelman; Daniel Levy; Warren J Manning
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

9.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).

Authors:  Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

10.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  42 in total

1.  Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex.

Authors:  Otavio R Coelho-Filho; Luciana F Seabra; François-Pierre Mongeon; Shuaib M Abdullah; Sanjeev A Francis; Ron Blankstein; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2011-08

2.  Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.

Authors:  Jennifer H Jordan; Jason C Haag; Timothy M Morgan; Sujethra Vasu; Brandon Stacey; Craig Hamilton; Killian Robinson; Dalane Kitzman; Vinay Thohan; William Gregory Hundley
Journal:  J Comput Assist Tomogr       Date:  2014 May-Jun       Impact factor: 1.826

Review 3.  Assessment of myocardial ischemia with cardiovascular magnetic resonance.

Authors:  Bobak Heydari; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Prog Cardiovasc Dis       Date:  2011 Nov-Dec       Impact factor: 8.194

4.  The role of cardiac magnetic resonance imaging following acute myocardial infarction.

Authors:  Dennis T L Wong; James D Richardson; Rishi Puri; Adam J Nelson; Angela G Bertaso; Karen S L Teo; Matthew I Worthley; Stephen G Worthley
Journal:  Eur Radiol       Date:  2012-03-25       Impact factor: 5.315

Review 5.  Cardiovascular magnetic resonance: applications in daily practice.

Authors:  Ronny S Jiji; Christopher M Kramer
Journal:  Cardiol Rev       Date:  2011 Sep-Oct       Impact factor: 2.644

Review 6.  Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.

Authors:  Marcelo S Nacif; Andrew E Arai; Joao A C Lima; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-29       Impact factor: 5.364

7.  Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease.

Authors:  Ravi Shah; Bobak Heydari; Otavio Coelho-Filho; Venkatesh L Murthy; Siddique Abbasi; Jiazhuo H Feng; Michael Pencina; Tomas G Neilan; Judith L Meadows; Sanjeev Francis; Ron Blankstein; Michael Steigner; Marcelo di Carli; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circulation       Date:  2013-06-26       Impact factor: 29.690

8.  Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.

Authors:  Neal K Lakdawala; Jens Jakob Thune; Barry J Maron; Allison L Cirino; Ole Havndrup; Henning Bundgaard; Michael Christiansen; Christian M Carlsen; Jean-François Dorval; Raymond Y Kwong; Steven D Colan; Lars V Køber; Carolyn Y Ho
Journal:  Am J Cardiol       Date:  2011-09-21       Impact factor: 2.778

Review 9.  Role of cardiac MRI in diabetes.

Authors:  Ravi V Shah; Siddique A Abbasi; Raymond Y Kwong
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

10.  Usefulness of Q-wave area for threshold-based stratification of global left ventricular myocardial infarct size.

Authors:  Jonathan D Kochav; Peter M Okin; Sean Wilson; Anika Afroz; Alfredo Renilla; Jonathan W Weinsaft
Journal:  Am J Cardiol       Date:  2013-04-20       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.